Analyst Ratings for Health Catalyst Inc. (HCAT)
HCAT Rating Summary
HCAT Price Target Summary
- Highest: $4.00 (KeyBanc)
- Lowest: $1.50 (Wells Fargo)
- Average: $2.40
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$2.40 (+40.4%)
* Over Last 12-Mos
Rating Score: 4.7 / 10
Percentile Rank: 47%
Avg. $ Target:
$2.40 (+40.4%)
* Over Last 12-Mos
Rating Score: 4.7 / 10
Percentile Rank: 47%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/20/2026 | Canaccord | Richard Close | Downgrade | Hold (Buy) |
1.80 (N/A) |
1.69 (1.71) |
1.18% | Details |
| 3/18/2026 | Wells Fargo » Updated 8/13/2026 |
Stan Berenshteyn | Downgrade | Equal Weight (Overweight) |
1.50 (1.75) |
1.22 (1.71) |
40.16% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
